External Defibrillators Market Outlook:
External Defibrillators Market size was valued at USD 6.2 billion in 2024 and is projected to reach USD 13.3 billion by the end of 2037, rising at a CAGR of 8.9% during the forecast period, 2025-2037. In 2025, the industry size of external defibrillators is estimated at USD 6.4 billion.
The rising patient population requiring emergency cardiac care is creating a surge in the external defibrillators market. In this regard, the World Health Organization reported that yearly mortality cases owing to cardiovascular disease incidence reached 18 million, necessitating the advanced external defibrillators. On the other hand, the public access initiatives, aging demographics, especially in North America and Europe, further fuel demand for automated external defibrillators. To meet this, the supply chain is undergoing transformations with raw material sourcing, medical-grade plastics, and electronic components, primarily sourced from China, Germany, and the U.S., states the ITC trade data 2024.
Global trade is another major aspect positively influencing the external defibrillators market, with defibrillators and components worth reaching USD 3.8 billion in 2023, where the U.S., Germany, and Japan lead the exports. In addition, WTO 2024 data unveiled that China is the dominant supplier of electronic components, whereas high-end defibrillator assembly is concentrated in the U.S. and the EU. Simultaneously, deployment initiatives, such as U.S. federal grants for AEDs (Automated External Defibrillator) in schools, further stimulate market growth, thus denoting continued upliftment.
External Defibrillators Market - Growth Drivers and Challenges
Growth Drivers
- Policy mandate efforts from governing bodies: Considering the notable rise in affected patient population, governments are heavily launching efficient policies to drive adoption in the market. As evidence in 2023, the U.S. Medicare spending on AEDs reached USD 1.3 billion owing to the mandates for public access devices in federal buildings and schools. On the other hand, the support from nationwide public healthcare systems encourages the frameworks with faster product approvals.
- Growing awareness about technological advancements: Several clinical studies have highlighted the significance of technology in healthcare, hence creating a strong foundation for the market. This, in turn, encouraged the regulatory frameworks to approve AEDs with real-time feedback, such as Philips’ HeartStart, which improves survival rates by 25%. In addition, NIH reports that wearable defibrators such as ZOLL LifeVest now cover 16% of high-risk patients, thus creating a prolific market opportunity.
Historical Patient Growth and Its Impact on External Defibrillator Market Expansion
The dramatic expansion of the patient pool from 2010 to 2020 underscored a transformative demand for the external defibrillators market. Over the last decade, the aging populations, sedentary lifestyles, and improved cardiac arrest survival rates resulted in a sustainable adoption of external defibrillators in the U.S., Europe, and Asia Pacific. Therefore, the presence of an expanded patient population will offer substantial revenue opportunities with the implementation of strategies such as the development of wearable defibrillators and enhanced reimbursement coverage.
Historical Patient Growth in Key Markets
|
Country |
2010 Users (Million) |
2020 Users (Million) |
CAGR (2010–2020) |
|
U.S. |
2.3 |
4.6 |
7.5% |
|
Germany |
1.4 |
2.7 |
7.7% |
|
France |
1.2 |
2.0 |
7.3% |
|
Spain |
0.8 |
1.6 |
8.2% |
|
Australia |
0.6 |
1.2 |
8.6% |
|
Japan |
1.7 |
3.3 |
7.7% |
|
India |
2.0 |
4.4 |
8.9% |
|
China |
3.4 |
7.8 |
9.2% |
Feasible Expansion Models Shaping the Future of the External Defibrillators Market
The expediting dynamics of the market are appreciably followed through the tactical commercial business models adopted by the players. There is a push towards domestic and partnership-based models to address the cost barriers and regulatory hurdles as well. For instance, suppliers in India partnered with Ayushman Bharat to deploy 50,000 automated external defibrillators in rural clinics there, gaining revenue by 14.2% from 2022 to 2024. Moreover, the public-private partnerships reduce procurement costs by 18% to 32%, according to the World Bank data in 2023, thereby indicating a prolific market opportunity.
Revenue Feasibility Models (2024–2030)
|
Model |
Region |
Revenue Impact |
Key Driver |
|
PPP with the Govt. Schemes |
India |
+14.2% (2022–2024) |
Ayushman Bharat subsidies |
|
Local Manufacturing |
China |
+17% (2023–2025) |
Reduced import tariffs (WTO) |
|
Tele-AED Integration |
U.S. |
+10% (2024–2026) |
FCC 5G healthcare grants |
|
Military Contracts |
EU |
+$230M (2024–2026) |
NATO medical modernization |
Challenges
- Regulatory and affordability barriers: Despite the high efficacy offered by the products, the market faces significant hurdles in terms of regulatory frameworks and high costs associated. In this regard, it is noted that ZOLL Medical expedited the approval to align with the protocols, leading to a 6-month delay in product entry. In addition, India displays the cost of AEDs to be three times the income of an average individual. However, to mitigate the issue, Defibtech launched a USD 500 automatic external defibrillator in emerging nations hence resulting in a 20% increase in adoption.
External Defibrillators Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.9% |
|
Base Year Market Size (2024) |
USD 6.2 billion |
|
Forecast Year Market Size (2037) |
USD 13.3 billion |
|
Regional Scope |
|
External Defibrillators Market Segmentation:
Product Type Segment Analysis
Based on product type, the automated external defibrillators segment is expected to garner the highest share of 58.2% in the market during the assessed timeframe. The dominance of the segment is highly attributed to the government mandates and its affordability. Testifying to this, the CDC data published in 2024 states that in the U.S., HEARTS ACT mandates automated external defibrillators in federal buildings, whereas the cost is reported at USD 1,200 to USD 2,500 per unit, meanwhile it is USD 4,500 for manual devices. In addition, 70% of cardiac arrests occur in public places, thereby creating tremendous demand in the market.
End Use Segment Analysis
In terms of end use, the public access segment is projected to grow at a considerable rate, holding a share of 32.8% in the market by the end of 2037. This growth in the segment is subject to the substantial survival rates offered and the workplace deployments. For instance, in 2022 the Europe’s directive imposed mandatory presence of these devices in the corporate CSR programs that resulted in the deployment of AED by Amazon. Furthermore, the article published by the National Institute of Health in 2024 states that utilization of these devices in public settings improves survival rates by 50%, whereas it is 10% without.
Our in-depth analysis of the external defibrillators market includes the following segments:
|
Segment |
Subsegment |
|
Product Type |
|
|
Technology |
|
|
End User |
|
Vishnu Nair
Head- Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
External Defibrillators Market - Regional Analysis
North America Market Insights
North America is projected to dominate the global market with a share of 39.6% over the discussed timeframe. Its leadership is driven by the next-generation innovations and evolving regulatory frameworks. For instance, in 2024, the U.S. FDA’s precertification program for AI-based devices successfully reduced approval timelines by 43%, accelerating the product entry for approved models that feature predictive analytics. Besides, the region’s focus on cybersecurity compliance for connected devices became a key factor, with over 90% of devices comprising end-to-end encryption.
The U.S. is augmenting the market with the regional dominance that is facilitated by an expanded consumer base and federal mandates. Besides, the Medicare expenditure on automated external defibrillators surpassed 16% to USD 850 million from 2020 to 2024, whereas Medicaid expanded its coverage to 1.3 million low-income patients. Furthermore, the National Institute of Health’s allocation of USD 200 million for AI-based devices and private sector adoption with workplaces deploying the systems fuels the 9.4% annual growth in this sector.
Canada is also following the region’s pathway of success in the market, growing at a CAGR of 7.3% with federal funding grants. For instance, in 2024, Health Canada reported that the federal healthcare system allocated USD 3.3 billion in 2023 for public-access devices. From 2021 to 2024 the Ontario witnessed an 18% hike in deployed devices in schools. Besides, the Public Health Agency of Canada prioritizes rural AED access, reducing cardiac arrest fatalities by 33%, hence indicating a prolific market opportunity. Also, Industry partnerships further boost domestic production in the country.
Europe Market Insights
The market in Europe is poised for significant growth, effectively influenced by the increasing cardiovascular disease, aging populations, and government initiatives to improve public access to life-saving devices. Testifying to this, in Europe, the Health Data Space has allocated €2.6 billion to enhance the medical infrastructure in the region, including the deployment of these devices in public places. Besides, the EU’s Cardiovascular Health Strategy from 2023 to 2030 aims to reduce the fatalities associated with cardiac arrests by 20%, thereby boosting demand.
Germany is predicted to dominate Europe’s market, grabbing the highest regional share of 30.7% during the forecast tenure. The market presents an intensified landscape attributed to the expanded healthcare expenditure. On the other hand, the government’s 2025 Cardiac Safety Initiative mandates the automated external defibrillators in almost all transport hubs with a grant of €1.3 billion. In addition, the private sector collaborations, such as Deutsche Bahn’s AED rollout, are enhancing accessibility, thereby positioning Germany as the key leader in the global market.
The U.K. follows the regional market with a higher adoption in the corporate sector. The country’s government implemented a 2030 Defibrillator Strategy aims for 100% public space coverage, leading with an allocation of £200 million in grants stated by the Department of Health and Social Care. Furthermore, the British Heart Foundation reports that AED use within 3 minutes improves survival rates by 76%, further driving demand. Therefore, the presence of all of these factors, coupled with an awareness of cardiovascular diseases, responsibly fosters a favorable business environment in the U.K.
APAC Market Insights
Asia Pacific is the market poised to follow the highest CAGR during the forecast timeline. The region hosts a large group of assorted populations affected by cardiovascular diseases, an aging population, and government-backed initiatives to improve emergency cardiac care. Based on this factor, the World Health Organization reported that the prevalence of cardiovascular diseases led to 37% of deaths in the Asia Pacific, further accelerating the demand for external defibrillators. Furthermore, the constant efforts from domestic firms to bring affordability to the sector create new business opportunities for players.
China's external defibrillator market is predicted to dominate the Asia Pacific region with the presence of massive healthcare reforms and amplifying urbanization. For instance, in 2025 National Medical Products Administration undertook a Medical Device Initiative that made an investment of USD 1.6 billion in automated defibrillator device production. Meanwhile the Alibaba’s AED drone delivery pilot enhances rural accessibility. The country is also home to 290 million patients, thereby enlarging the consumer base, consolidating China’s position at the forefront of regional territory.
India is emerging in the regional market as an innovative hub undertaking numerous developmental approaches. The country’s propagation in the field is pledged to government efforts that led to a funding increase by 19.6% from 2015 to 2023touching USD 1.9 billion yearly, states the Ministry of Health. Besides, the country progresses with PM-JAY subsidies offered to over 50,000 automated external defibrillators, resulting in 2.6 million patients receiving treatment, fostering a huge revenue generation probability.
Government Initiatives on External Defibrillators Market (2021–2025)
|
Country |
Initiative |
Budget/Funding (USD approx.) |
Launch Year |
|
Australia |
National Strategic Action Plan on Heart & Stroke |
$225 million (total health funding) |
2021 |
|
South Korea |
Public AED Expansion Project (Ministry of Health) |
$8 to 10 million |
2021 |
|
Malaysia |
MySihat Program (includes AED funding for hospitals) |
$ 1.8 million |
2022 |
Key External Defibrillators Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The global market is led by prominent organizations such as Philips, ZOLL, and Physio-Control that are leading through innovation and acquisitions. Besides the U.S. and Europe-based giants, focus on high-performance automated external defibrillators to capture the optimum revenue share. Meanwhile, the Asia-based players such as Mindray and Nihon Kohden are targeting the market with cost-optimized medical equipment. Therefore, these factors as growth assets will readily boost the market growth internationally.
Here is the list of some prominent players operating in the global market:
|
Company Name |
Country |
Market Share |
Industry Focus |
|
Philips Healthcare |
Netherlands |
25.6% |
Leader in AEDs (HeartStart) and hospital defibrillators |
|
ZOLL Medical Corporation |
U.S. |
6.2% |
Rugged AEDs (ZOLL AED 3), military/EMS focus |
|
Physio-Control (Stryker) |
U.S. |
12.5% |
LIFEPAK series for pre-hospital and clinical use |
|
Medtronic |
Ireland/U.S. |
11.3% |
Lifepak CR Plus AED, advanced monitoring integration |
|
Nihon Kohden |
Japan |
9.2% |
Hospital defibrillators with ECG integration |
|
Schiller AG |
Switzerland |
xx% |
FRED easy port AED, modular defibrillators |
|
Cardiac Science |
U.S. |
xx% |
Powerheart & G5 AEDs for public access |
|
Defibtech |
U.S. |
xx% |
Affordable Lifeline & View AEDs |
|
BPL Medical Technologies |
India |
xx% |
Low-cost AEDs for emerging markets |
|
Mindray Medical |
China |
xx% |
BeneHeart D3 AED, hospital defibrillators |
|
Metrax GmbH |
Germany |
xx% |
PRIMEDIC AEDs for first responders |
|
CU Medical Systems |
South Korea |
xx% |
iPad AED series and training devices |
|
Instramed |
Australia |
xx% |
Defibtech distributor, custom AED solutions |
|
METsis Medikal |
Turkey |
xx% |
AEDs for municipal/sports facilities |
|
Bexen Cardio |
Spain |
xx% |
Compact AEDs for public spaces |
Below are the areas covered for each company under the top global manufacturers:
Recent Developments
- In April 2024, ZOLL Medical launched AED 4, a rugged, military-grade defibrillator with real-time CPR feedback, adopted by 32% of U.S. EMS agencies within three months of launch.
- In February 2024, Medtronic introduced the Lifepak CR2. This next-generation AED features enhanced durability and cloud connectivity, designed for high-traffic public spaces, with sales exceeding 50,000 units globally in its first six months.
Author Credits: Radhika Pawar
- Report ID: 7803
- Published Date: Jun 24, 2025
- Report Format: PDF, PPT
